Spaces:
Running
Running
Upload index.html
Browse files- index.html +494 -0
index.html
ADDED
|
@@ -0,0 +1,494 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
<!DOCTYPE html>
|
| 2 |
+
<html lang="en">
|
| 3 |
+
<head>
|
| 4 |
+
<meta charset="UTF-8">
|
| 5 |
+
<meta name="viewport" content="width=device-width, initial-scale=1.0">
|
| 6 |
+
<title>Preserflo™ MicroShunt - Advanced Glaucoma Treatment</title>
|
| 7 |
+
|
| 8 |
+
<!-- Reveal.js -->
|
| 9 |
+
<link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/reveal.js/4.5.0/reveal.min.css">
|
| 10 |
+
<link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/reveal.js/4.5.0/theme/white.min.css">
|
| 11 |
+
|
| 12 |
+
<!-- Tailwind CSS -->
|
| 13 |
+
<script src="https://cdn.tailwindcss.com"></script>
|
| 14 |
+
|
| 15 |
+
<!-- Font Awesome -->
|
| 16 |
+
<link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css">
|
| 17 |
+
|
| 18 |
+
<style>
|
| 19 |
+
.reveal section {
|
| 20 |
+
height: 100%;
|
| 21 |
+
}
|
| 22 |
+
.reveal h1 {
|
| 23 |
+
font-size: 2.5em;
|
| 24 |
+
color: #1a365d;
|
| 25 |
+
}
|
| 26 |
+
.reveal h2 {
|
| 27 |
+
font-size: 1.8em;
|
| 28 |
+
color: #2c5282;
|
| 29 |
+
}
|
| 30 |
+
.reveal p {
|
| 31 |
+
font-size: 1.2em;
|
| 32 |
+
line-height: 1.6;
|
| 33 |
+
}
|
| 34 |
+
.reveal ul {
|
| 35 |
+
list-style-type: none;
|
| 36 |
+
margin-left: 1em;
|
| 37 |
+
}
|
| 38 |
+
.reveal li {
|
| 39 |
+
margin: 0.8em 0;
|
| 40 |
+
display: flex;
|
| 41 |
+
align-items: center;
|
| 42 |
+
}
|
| 43 |
+
.reveal li i {
|
| 44 |
+
margin-right: 0.5em;
|
| 45 |
+
color: #2c5282;
|
| 46 |
+
}
|
| 47 |
+
.custom-bg {
|
| 48 |
+
background-color: rgba(255, 255, 255, 0.95);
|
| 49 |
+
padding: 2rem;
|
| 50 |
+
border-radius: 1rem;
|
| 51 |
+
box-shadow: 0 4px 6px rgba(0, 0, 0, 0.1);
|
| 52 |
+
}
|
| 53 |
+
.medical-icon {
|
| 54 |
+
font-size: 1.2em;
|
| 55 |
+
color: #2c5282;
|
| 56 |
+
}
|
| 57 |
+
.img-container {
|
| 58 |
+
position: relative;
|
| 59 |
+
overflow: hidden;
|
| 60 |
+
border-radius: 0.5rem;
|
| 61 |
+
box-shadow: 0 4px 6px rgba(0, 0, 0, 0.1);
|
| 62 |
+
aspect-ratio: 4/3;
|
| 63 |
+
background: white;
|
| 64 |
+
}
|
| 65 |
+
.img-container img {
|
| 66 |
+
width: 100%;
|
| 67 |
+
height: 100%;
|
| 68 |
+
object-fit: contain;
|
| 69 |
+
padding: 1rem;
|
| 70 |
+
}
|
| 71 |
+
.chart-container {
|
| 72 |
+
background: white;
|
| 73 |
+
padding: 1.5rem;
|
| 74 |
+
border-radius: 0.5rem;
|
| 75 |
+
box-shadow: 0 4px 6px rgba(0, 0, 0, 0.1);
|
| 76 |
+
margin: 1rem 0;
|
| 77 |
+
}
|
| 78 |
+
.comparison-chart {
|
| 79 |
+
display: flex;
|
| 80 |
+
flex-direction: column;
|
| 81 |
+
gap: 1rem;
|
| 82 |
+
}
|
| 83 |
+
.bar {
|
| 84 |
+
background: linear-gradient(to right, #3b82f6, #60a5fa);
|
| 85 |
+
height: 2rem;
|
| 86 |
+
border-radius: 0.25rem;
|
| 87 |
+
transition: width 0.3s ease;
|
| 88 |
+
position: relative;
|
| 89 |
+
}
|
| 90 |
+
.bar::after {
|
| 91 |
+
content: attr(data-value);
|
| 92 |
+
position: absolute;
|
| 93 |
+
right: 8px;
|
| 94 |
+
top: 50%;
|
| 95 |
+
transform: translateY(-50%);
|
| 96 |
+
color: white;
|
| 97 |
+
font-weight: bold;
|
| 98 |
+
}
|
| 99 |
+
.stat-grid {
|
| 100 |
+
display: grid;
|
| 101 |
+
grid-template-columns: repeat(2, 1fr);
|
| 102 |
+
gap: 1rem;
|
| 103 |
+
}
|
| 104 |
+
.stat-card {
|
| 105 |
+
background: white;
|
| 106 |
+
padding: 1.5rem;
|
| 107 |
+
border-radius: 0.5rem;
|
| 108 |
+
box-shadow: 0 4px 6px rgba(0, 0, 0, 0.1);
|
| 109 |
+
text-align: center;
|
| 110 |
+
transition: transform 0.2s ease;
|
| 111 |
+
}
|
| 112 |
+
.stat-card:hover {
|
| 113 |
+
transform: translateY(-2px);
|
| 114 |
+
}
|
| 115 |
+
.stat-number {
|
| 116 |
+
font-size: 2.5rem;
|
| 117 |
+
font-weight: bold;
|
| 118 |
+
color: #2563eb;
|
| 119 |
+
margin-bottom: 0.5rem;
|
| 120 |
+
}
|
| 121 |
+
.chart-title {
|
| 122 |
+
font-size: 1.2rem;
|
| 123 |
+
font-weight: 600;
|
| 124 |
+
color: #1e40af;
|
| 125 |
+
margin-bottom: 1rem;
|
| 126 |
+
text-align: center;
|
| 127 |
+
}
|
| 128 |
+
.line-chart {
|
| 129 |
+
width: 100%;
|
| 130 |
+
height: 200px;
|
| 131 |
+
margin-top: 1rem;
|
| 132 |
+
}
|
| 133 |
+
.axis-label {
|
| 134 |
+
font-size: 0.875rem;
|
| 135 |
+
fill: #64748b;
|
| 136 |
+
}
|
| 137 |
+
.data-point {
|
| 138 |
+
fill: #3b82f6;
|
| 139 |
+
r: 4;
|
| 140 |
+
}
|
| 141 |
+
.data-line {
|
| 142 |
+
stroke: #3b82f6;
|
| 143 |
+
stroke-width: 2;
|
| 144 |
+
fill: none;
|
| 145 |
+
}
|
| 146 |
+
</style>
|
| 147 |
+
</head>
|
| 148 |
+
<body>
|
| 149 |
+
<div class="reveal">
|
| 150 |
+
<div class="slides">
|
| 151 |
+
<!-- Title Slide -->
|
| 152 |
+
<section class="bg-gradient-to-r from-blue-100 to-blue-200">
|
| 153 |
+
<div class="custom-bg">
|
| 154 |
+
<i class="fas fa-eye medical-icon text-5xl mb-6"></i>
|
| 155 |
+
<h1 class="text-4xl font-bold mb-6">Preserflo™ MicroShunt</h1>
|
| 156 |
+
<h2 class="text-2xl text-gray-700 mb-4">Advanced Glaucoma Treatment Solution</h2>
|
| 157 |
+
<p class="text-lg text-gray-600">A Revolutionary Approach to IOP Management</p>
|
| 158 |
+
</div>
|
| 159 |
+
</section>
|
| 160 |
+
|
| 161 |
+
<!-- What is Glaucoma? -->
|
| 162 |
+
<section>
|
| 163 |
+
<div class="custom-bg">
|
| 164 |
+
<h2 class="text-3xl font-bold mb-6">Understanding Glaucoma</h2>
|
| 165 |
+
<div class="grid grid-cols-2 gap-8">
|
| 166 |
+
<div>
|
| 167 |
+
<ul class="text-left">
|
| 168 |
+
<li><i class="fas fa-exclamation-triangle"></i>Progressive optic nerve damage</li>
|
| 169 |
+
<li><i class="fas fa-arrow-up"></i>Often associated with elevated intraocular pressure (IOP)</li>
|
| 170 |
+
<li><i class="fas fa-eye-slash"></i>Leading cause of irreversible blindness worldwide</li>
|
| 171 |
+
<li><i class="fas fa-users"></i>Affects over 80 million people globally</li>
|
| 172 |
+
</ul>
|
| 173 |
+
<div class="chart-container mt-4">
|
| 174 |
+
<div class="chart-title">Global Impact of Glaucoma</div>
|
| 175 |
+
<div class="stat-grid">
|
| 176 |
+
<div class="stat-card">
|
| 177 |
+
<div class="stat-number">80M+</div>
|
| 178 |
+
<div>Global Cases</div>
|
| 179 |
+
</div>
|
| 180 |
+
<div class="stat-card">
|
| 181 |
+
<div class="stat-number">2nd</div>
|
| 182 |
+
<div>Leading Cause of Blindness</div>
|
| 183 |
+
</div>
|
| 184 |
+
</div>
|
| 185 |
+
</div>
|
| 186 |
+
</div>
|
| 187 |
+
<div class="flex items-center justify-center">
|
| 188 |
+
<div class="img-container">
|
| 189 |
+
<img src="https://upload.wikimedia.org/wikipedia/commons/thumb/f/f7/Eye_diagram-en.svg/1280px-Eye_diagram-en.svg.png" alt="Eye Anatomy Diagram" class="rounded-lg shadow-lg">
|
| 190 |
+
</div>
|
| 191 |
+
</div>
|
| 192 |
+
</div>
|
| 193 |
+
</div>
|
| 194 |
+
</section>
|
| 195 |
+
|
| 196 |
+
<!-- What is Preserflo? -->
|
| 197 |
+
<section>
|
| 198 |
+
<div class="custom-bg">
|
| 199 |
+
<h2 class="text-3xl font-bold mb-6">The Preserflo™ MicroShunt</h2>
|
| 200 |
+
<div class="grid grid-cols-2 gap-8">
|
| 201 |
+
<div>
|
| 202 |
+
<ul class="text-left mb-4">
|
| 203 |
+
<li><i class="fas fa-microscope"></i>Ultra-stable, biocompatible SIBS material</li>
|
| 204 |
+
<li><i class="fas fa-ruler-combined"></i>Dimensions: 8.5mm long, 350μm external diameter</li>
|
| 205 |
+
<li><i class="fas fa-lock"></i>Planar fins prevent rotation and migration</li>
|
| 206 |
+
<li><i class="fas fa-drafting-compass"></i>Precisely engineered internal lumen (70μm)</li>
|
| 207 |
+
</ul>
|
| 208 |
+
<div class="chart-container">
|
| 209 |
+
<div class="chart-title">Device Specifications</div>
|
| 210 |
+
<svg width="100%" height="160" class="device-diagram">
|
| 211 |
+
<defs>
|
| 212 |
+
<linearGradient id="deviceGradient" x1="0%" y1="0%" x2="100%" y2="0%">
|
| 213 |
+
<stop offset="0%" style="stop-color:#3b82f6;stop-opacity:1" />
|
| 214 |
+
<stop offset="100%" style="stop-color:#60a5fa;stop-opacity:1" />
|
| 215 |
+
</linearGradient>
|
| 216 |
+
</defs>
|
| 217 |
+
<rect x="10%" y="40" width="80%" height="40" fill="url(#deviceGradient)" rx="20"/>
|
| 218 |
+
<text x="50%" y="65" text-anchor="middle" fill="white" font-weight="bold">8.5mm length</text>
|
| 219 |
+
<line x1="10%" y1="100" x2="90%" y2="100" stroke="#2563eb" stroke-width="2"/>
|
| 220 |
+
<text x="50%" y="115" text-anchor="middle" fill="#2563eb">350μm external diameter</text>
|
| 221 |
+
<circle cx="25%" cy="60" r="5" fill="#fff"/>
|
| 222 |
+
<circle cx="75%" cy="60" r="5" fill="#fff"/>
|
| 223 |
+
<text x="50%" y="140" text-anchor="middle" fill="#64748b" font-size="12">Internal lumen: 70μm</text>
|
| 224 |
+
</svg>
|
| 225 |
+
</div>
|
| 226 |
+
</div>
|
| 227 |
+
<div class="flex items-center justify-center">
|
| 228 |
+
<div class="img-container">
|
| 229 |
+
<img src="https://upload.wikimedia.org/wikipedia/commons/thumb/b/b2/Glaucoma_drainage_device.jpg/1280px-Glaucoma_drainage_device.jpg" alt="Medical Device" class="rounded-lg shadow-lg">
|
| 230 |
+
</div>
|
| 231 |
+
</div>
|
| 232 |
+
</div>
|
| 233 |
+
</div>
|
| 234 |
+
</section>
|
| 235 |
+
|
| 236 |
+
<!-- How it Works -->
|
| 237 |
+
<section>
|
| 238 |
+
<div class="custom-bg">
|
| 239 |
+
<h2 class="text-3xl font-bold mb-6">Mechanism of Action</h2>
|
| 240 |
+
<div class="grid grid-cols-2 gap-8">
|
| 241 |
+
<div>
|
| 242 |
+
<ul class="text-left mb-4">
|
| 243 |
+
<li><i class="fas fa-route"></i>Creates controlled aqueous outflow pathway</li>
|
| 244 |
+
<li><i class="fas fa-exchange-alt"></i>Diverts fluid from anterior chamber to subconjunctival space</li>
|
| 245 |
+
<li><i class="fas fa-filter"></i>Forms a posterior filtration bleb</li>
|
| 246 |
+
<li><i class="fas fa-cogs"></i>Maintains optimal IOP through precise engineering</li>
|
| 247 |
+
</ul>
|
| 248 |
+
<div class="chart-container">
|
| 249 |
+
<div class="chart-title">Aqueous Flow Pathway</div>
|
| 250 |
+
<svg width="100%" height="180">
|
| 251 |
+
<defs>
|
| 252 |
+
<marker id="arrowhead" markerWidth="10" markerHeight="7" refX="9" refY="3.5" orient="auto">
|
| 253 |
+
<polygon points="0 0, 10 3.5, 0 7" fill="#3b82f6"/>
|
| 254 |
+
</marker>
|
| 255 |
+
<linearGradient id="flowGradient" x1="0%" y1="0%" x2="100%" y2="0%">
|
| 256 |
+
<stop offset="0%" style="stop-color:#3b82f6;stop-opacity:0.2" />
|
| 257 |
+
<stop offset="100%" style="stop-color:#60a5fa;stop-opacity:0.2" />
|
| 258 |
+
</linearGradient>
|
| 259 |
+
</defs>
|
| 260 |
+
<rect x="10%" y="20" width="80%" height="140" fill="url(#flowGradient)" rx="10"/>
|
| 261 |
+
<path d="M50,90 Q150,40 250,90" stroke="#3b82f6" stroke-width="3" fill="none" marker-end="url(#arrowhead)"/>
|
| 262 |
+
<circle cx="50" cy="90" r="8" fill="#3b82f6"/>
|
| 263 |
+
<circle cx="250" cy="90" r="8" fill="#60a5fa"/>
|
| 264 |
+
<text x="50" y="120" text-anchor="middle" fill="#2563eb" font-weight="bold">Anterior Chamber</text>
|
| 265 |
+
<text x="250" y="120" text-anchor="middle" fill="#2563eb" font-weight="bold">Subconjunctival Space</text>
|
| 266 |
+
<text x="150" y="40" text-anchor="middle" fill="#64748b">Controlled Flow</text>
|
| 267 |
+
</svg>
|
| 268 |
+
</div>
|
| 269 |
+
</div>
|
| 270 |
+
<div class="flex items-center justify-center">
|
| 271 |
+
<div class="img-container">
|
| 272 |
+
<img src="https://upload.wikimedia.org/wikipedia/commons/thumb/2/2c/Glaucoma_Types.png/1280px-Glaucoma_Types.png" alt="Glaucoma Mechanism" class="rounded-lg shadow-lg">
|
| 273 |
+
</div>
|
| 274 |
+
</div>
|
| 275 |
+
</div>
|
| 276 |
+
</div>
|
| 277 |
+
</section>
|
| 278 |
+
|
| 279 |
+
<!-- Indications -->
|
| 280 |
+
<section>
|
| 281 |
+
<div class="custom-bg">
|
| 282 |
+
<h2 class="text-3xl font-bold mb-6">Clinical Indications</h2>
|
| 283 |
+
<div class="grid grid-cols-2 gap-8">
|
| 284 |
+
<div>
|
| 285 |
+
<ul class="text-left">
|
| 286 |
+
<li><i class="fas fa-clipboard-check"></i>Primary Open-Angle Glaucoma (POAG)</li>
|
| 287 |
+
<li><i class="fas fa-chart-line"></i>Uncontrolled IOP despite maximum medical therapy</li>
|
| 288 |
+
<li><i class="fas fa-history"></i>Failed previous glaucoma surgeries</li>
|
| 289 |
+
<li><i class="fas fa-allergies"></i>Patients intolerant to medication</li>
|
| 290 |
+
</ul>
|
| 291 |
+
</div>
|
| 292 |
+
<div class="flex items-center justify-center">
|
| 293 |
+
<div class="img-container">
|
| 294 |
+
<img src="https://images.unsplash.com/photo-1576091160291-31957ab2724d?auto=format&fit=crop&w=800" alt="Patient Consultation" class="rounded-lg shadow-lg">
|
| 295 |
+
</div>
|
| 296 |
+
</div>
|
| 297 |
+
</div>
|
| 298 |
+
</div>
|
| 299 |
+
</section>
|
| 300 |
+
|
| 301 |
+
<!-- The Procedure -->
|
| 302 |
+
<section>
|
| 303 |
+
<div class="custom-bg">
|
| 304 |
+
<h2 class="text-3xl font-bold mb-6">Surgical Procedure</h2>
|
| 305 |
+
<div class="grid grid-cols-2 gap-8">
|
| 306 |
+
<div>
|
| 307 |
+
<ul class="text-left">
|
| 308 |
+
<li><i class="fas fa-hospital-user"></i>Outpatient procedure under local anesthesia</li>
|
| 309 |
+
<li><i class="fas fa-vial"></i>MMC application for bleb modulation</li>
|
| 310 |
+
<li><i class="fas fa-crosshairs"></i>Precise placement in anterior chamber</li>
|
| 311 |
+
<li><i class="fas fa-hand-holding-medical"></i>Minimal tissue disruption</li>
|
| 312 |
+
</ul>
|
| 313 |
+
</div>
|
| 314 |
+
<div class="flex items-center justify-center">
|
| 315 |
+
<div class="img-container">
|
| 316 |
+
<img src="https://images.unsplash.com/photo-1576091160702-a1607572684d?auto=format&fit=crop&w=800" alt="Surgical Environment" class="rounded-lg shadow-lg">
|
| 317 |
+
</div>
|
| 318 |
+
</div>
|
| 319 |
+
</div>
|
| 320 |
+
</div>
|
| 321 |
+
</section>
|
| 322 |
+
|
| 323 |
+
<!-- Benefits -->
|
| 324 |
+
<section>
|
| 325 |
+
<div class="custom-bg">
|
| 326 |
+
<h2 class="text-3xl font-bold mb-6">Clinical Benefits</h2>
|
| 327 |
+
<div class="grid grid-cols-2 gap-8">
|
| 328 |
+
<div>
|
| 329 |
+
<ul class="text-left mb-4">
|
| 330 |
+
<li><i class="fas fa-chart-bar"></i>Significant and sustained IOP reduction</li>
|
| 331 |
+
<li><i class="fas fa-pills"></i>Reduced dependency on medications</li>
|
| 332 |
+
<li><i class="fas fa-check-circle"></i>Standardized surgical technique</li>
|
| 333 |
+
<li><i class="fas fa-running"></i>Faster recovery compared to traditional surgery</li>
|
| 334 |
+
</ul>
|
| 335 |
+
<div class="chart-container">
|
| 336 |
+
<div class="chart-title">IOP Reduction Results</div>
|
| 337 |
+
<div class="comparison-chart">
|
| 338 |
+
<div>
|
| 339 |
+
<div class="flex justify-between mb-1">
|
| 340 |
+
<span class="font-semibold">Baseline IOP</span>
|
| 341 |
+
<span class="font-semibold">24.8 mmHg</span>
|
| 342 |
+
</div>
|
| 343 |
+
<div class="bar" style="width: 100%" data-value="24.8 mmHg"></div>
|
| 344 |
+
</div>
|
| 345 |
+
<div>
|
| 346 |
+
<div class="flex justify-between mb-1">
|
| 347 |
+
<span class="font-semibold">6 Months Post-Op</span>
|
| 348 |
+
<span class="font-semibold">13.7 mmHg</span>
|
| 349 |
+
</div>
|
| 350 |
+
<div class="bar" style="width: 55%" data-value="13.7 mmHg"></div>
|
| 351 |
+
</div>
|
| 352 |
+
<div>
|
| 353 |
+
<div class="flex justify-between mb-1">
|
| 354 |
+
<span class="font-semibold">12 Months Post-Op</span>
|
| 355 |
+
<span class="font-semibold">12.9 mmHg</span>
|
| 356 |
+
</div>
|
| 357 |
+
<div class="bar" style="width: 52%" data-value="12.9 mmHg"></div>
|
| 358 |
+
</div>
|
| 359 |
+
</div>
|
| 360 |
+
</div>
|
| 361 |
+
</div>
|
| 362 |
+
<div class="flex items-center justify-center">
|
| 363 |
+
<div class="img-container">
|
| 364 |
+
<img src="https://upload.wikimedia.org/wikipedia/commons/thumb/e/ec/Fundus_photograph_of_normal_right_eye.jpg/1280px-Fundus_photograph_of_normal_right_eye.jpg" alt="Clinical Benefits" class="rounded-lg shadow-lg">
|
| 365 |
+
</div>
|
| 366 |
+
</div>
|
| 367 |
+
</div>
|
| 368 |
+
</div>
|
| 369 |
+
</section>
|
| 370 |
+
|
| 371 |
+
<!-- Comparison with Trabeculectomy -->
|
| 372 |
+
<section>
|
| 373 |
+
<div class="custom-bg">
|
| 374 |
+
<h2 class="text-3xl font-bold mb-6">Preserflo™ vs. Trabeculectomy</h2>
|
| 375 |
+
<div class="grid grid-cols-2 gap-6">
|
| 376 |
+
<div class="bg-blue-50 p-6 rounded-lg">
|
| 377 |
+
<h3 class="text-xl font-semibold mb-3"><i class="fas fa-star mr-2"></i>Preserflo™ MicroShunt</h3>
|
| 378 |
+
<ul class="text-left text-sm">
|
| 379 |
+
<li><i class="fas fa-check text-green-500"></i>Standardized procedure</li>
|
| 380 |
+
<li><i class="fas fa-check text-green-500"></i>Lower risk of hypotony</li>
|
| 381 |
+
<li><i class="fas fa-check text-green-500"></i>Faster visual recovery</li>
|
| 382 |
+
<li><i class="fas fa-check text-green-500"></i>Fewer post-op interventions</li>
|
| 383 |
+
</ul>
|
| 384 |
+
</div>
|
| 385 |
+
<div class="bg-gray-50 p-6 rounded-lg">
|
| 386 |
+
<h3 class="text-xl font-semibold mb-3"><i class="fas fa-hospital mr-2"></i>Trabeculectomy</h3>
|
| 387 |
+
<ul class="text-left text-sm">
|
| 388 |
+
<li><i class="fas fa-exclamation-circle text-red-500"></i>More surgeon dependent</li>
|
| 389 |
+
<li><i class="fas fa-exclamation-circle text-red-500"></i>Higher risk of complications</li>
|
| 390 |
+
<li><i class="fas fa-exclamation-circle text-red-500"></i>Longer recovery period</li>
|
| 391 |
+
<li><i class="fas fa-exclamation-circle text-red-500"></i>More frequent follow-up needed</li>
|
| 392 |
+
</ul>
|
| 393 |
+
</div>
|
| 394 |
+
</div>
|
| 395 |
+
</div>
|
| 396 |
+
</section>
|
| 397 |
+
|
| 398 |
+
<!-- Safety Considerations -->
|
| 399 |
+
<section>
|
| 400 |
+
<div class="custom-bg">
|
| 401 |
+
<h2 class="text-3xl font-bold mb-6">Safety Profile</h2>
|
| 402 |
+
<div class="grid grid-cols-2 gap-8">
|
| 403 |
+
<div>
|
| 404 |
+
<ul class="text-left">
|
| 405 |
+
<li><i class="fas fa-shield-alt"></i>Lower risk of hypotony compared to trabeculectomy</li>
|
| 406 |
+
<li><i class="fas fa-check-shield"></i>Minimal risk of device erosion</li>
|
| 407 |
+
<li><i class="fas fa-virus-slash"></i>Reduced risk of infection</li>
|
| 408 |
+
<li><i class="fas fa-user-nurse"></i>Manageable post-operative care</li>
|
| 409 |
+
</ul>
|
| 410 |
+
</div>
|
| 411 |
+
<div class="flex items-center justify-center">
|
| 412 |
+
<div class="img-container">
|
| 413 |
+
<img src="https://upload.wikimedia.org/wikipedia/commons/thumb/9/95/Ophthalmology_symbol.svg/1280px-Ophthalmology_symbol.svg.png" alt="Safety Measures" class="rounded-lg shadow-lg">
|
| 414 |
+
</div>
|
| 415 |
+
</div>
|
| 416 |
+
</div>
|
| 417 |
+
</div>
|
| 418 |
+
</section>
|
| 419 |
+
|
| 420 |
+
<!-- Clinical Evidence -->
|
| 421 |
+
<section>
|
| 422 |
+
<div class="custom-bg">
|
| 423 |
+
<h2 class="text-3xl font-bold mb-6">Clinical Evidence</h2>
|
| 424 |
+
<div class="grid grid-cols-2 gap-8">
|
| 425 |
+
<div>
|
| 426 |
+
<ul class="text-left mb-4">
|
| 427 |
+
<li><i class="fas fa-chart-pie"></i>High success rates in clinical trials</li>
|
| 428 |
+
<li><i class="fas fa-percent"></i>Significant IOP reduction (40-50%)</li>
|
| 429 |
+
<li><i class="fas fa-prescription"></i>Medication reduction in most patients</li>
|
| 430 |
+
<li><i class="fas fa-clock"></i>Sustained effectiveness over time</li>
|
| 431 |
+
</ul>
|
| 432 |
+
<div class="chart-container">
|
| 433 |
+
<div class="chart-title">Success Rates at 12 Months</div>
|
| 434 |
+
<div class="stat-grid">
|
| 435 |
+
<div class="stat-card">
|
| 436 |
+
<i class="fas fa-check-double text-3xl text-green-600 mb-2"></i>
|
| 437 |
+
<div class="stat-number">83.3%</div>
|
| 438 |
+
<div>Complete Success</div>
|
| 439 |
+
<div class="text-sm text-gray-600">No Medications</div>
|
| 440 |
+
</div>
|
| 441 |
+
<div class="stat-card">
|
| 442 |
+
<i class="fas fa-star text-3xl text-blue-600 mb-2"></i>
|
| 443 |
+
<div class="stat-number">94.8%</div>
|
| 444 |
+
<div>Qualified Success</div>
|
| 445 |
+
<div class="text-sm text-gray-600">≤ 2 Medications</div>
|
| 446 |
+
</div>
|
| 447 |
+
</div>
|
| 448 |
+
</div>
|
| 449 |
+
</div>
|
| 450 |
+
<div class="flex items-center justify-center">
|
| 451 |
+
<div class="img-container">
|
| 452 |
+
<img src="https://upload.wikimedia.org/wikipedia/commons/thumb/8/8d/DNA_orbit_animated.gif/1280px-DNA_orbit_animated.gif" alt="Clinical Research" class="rounded-lg shadow-lg">
|
| 453 |
+
</div>
|
| 454 |
+
</div>
|
| 455 |
+
</div>
|
| 456 |
+
</div>
|
| 457 |
+
</section>
|
| 458 |
+
|
| 459 |
+
<!-- Conclusion -->
|
| 460 |
+
<section class="bg-gradient-to-r from-blue-100 to-blue-200">
|
| 461 |
+
<div class="custom-bg">
|
| 462 |
+
<h2 class="text-3xl font-bold mb-6">Conclusion</h2>
|
| 463 |
+
<div class="grid grid-cols-1 gap-6">
|
| 464 |
+
<div class="text-left">
|
| 465 |
+
<p class="mb-4"><i class="fas fa-award text-2xl mr-3"></i>The Preserflo™ MicroShunt represents a significant advancement in glaucoma surgery:</p>
|
| 466 |
+
<ul class="text-left">
|
| 467 |
+
<li><i class="fas fa-lightbulb"></i>Innovative design with proven effectiveness</li>
|
| 468 |
+
<li><i class="fas fa-tasks"></i>Standardized surgical technique</li>
|
| 469 |
+
<li><i class="fas fa-shield-check"></i>Excellent safety profile</li>
|
| 470 |
+
<li><i class="fas fa-star"></i>Potential to become the new standard of care</li>
|
| 471 |
+
</ul>
|
| 472 |
+
</div>
|
| 473 |
+
</div>
|
| 474 |
+
</div>
|
| 475 |
+
</section>
|
| 476 |
+
|
| 477 |
+
</div>
|
| 478 |
+
</div>
|
| 479 |
+
|
| 480 |
+
<!-- Reveal.js Scripts -->
|
| 481 |
+
<script src="https://cdnjs.cloudflare.com/ajax/libs/reveal.js/4.5.0/reveal.min.js"></script>
|
| 482 |
+
<script>
|
| 483 |
+
Reveal.initialize({
|
| 484 |
+
hash: true,
|
| 485 |
+
center: true,
|
| 486 |
+
progress: true,
|
| 487 |
+
controls: true,
|
| 488 |
+
transition: 'slide',
|
| 489 |
+
width: 1200,
|
| 490 |
+
height: 800
|
| 491 |
+
});
|
| 492 |
+
</script>
|
| 493 |
+
</body>
|
| 494 |
+
</html>
|